GlassScriptPhysician profile
Christopher Douglas Vije
NPI 1316009525
$14,464.61
in general payments reported to CMS, 2019-2025
33 companies · $1,609 in 2025
The $1,609 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,556 · 2020: $1,405 · 2021: $1,359 · 2022: $1,999 · 2023: $2,195 · 2024: $4,343 · 2025: $1,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,206 · Travel and Lodging: $690 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,206.13 |
| Travel and Lodging | $690.16 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,598.53 | 2019-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $1,129.00 | 2023-2025 | |
| Vertos Medical, INC. | $693.97 | 2023-2024 | Mild Device Kit |
| Medtronic, INC. | $525.45 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $495.50 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Zyla Life Sciences, INC. | $468.74 | 2019-2020 | |
| Abbvie INC. | $287.15 | 2023-2025 | Botox, Ubrelvy |
| Redhill Biopharma INC. | $217.73 | 2020-2021 | |
| Pacira Therapeutics, INC. | $210.02 | 2019-2021 | |
| Relievant Medsystems, INC. | $199.83 | 2021-2023 | Intracept |
| Spinal Simplicity, LLC | $155.63 | 2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $150.85 | 2022-2025 | Belbuca, Xtampza |
| Arbor Pharmaceuticals, INC. | $143.12 | 2019-2022 | |
| Pfizer INC. | $125.66 | 2019-2024 | |
| Stryker Corporation | $116.51 | 2020-2025 | Augment Injectable |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $99.24 | 2024 | Evoke |
| Averitas Pharma INC. | $93.43 | 2024-2025 | Qutenza |
| Scilex Pharmaceuticals INC. | $79.66 | 2019-2020 | |
| Depuy Synthes Sales INC. | $67.00 | 2020-2024 | Confidence Spinal Cement System, Synflate |
| Radius Health, INC. | $66.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $59.71 | 2022-2023 | Seglentis |
| Painteq LLC | $55.82 | 2023-2024 | Painteq |
| Orthogenrx INC. | $52.44 | 2019 | |
| Grt US Holding, INC. | $51.00 | 2022 | |
| Curonix LLC | $50.18 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.60 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $43.51 | 2019-2021 | |
| Lilly USA, LLC | $37.63 | 2024 | Emgality, Reyvow |
| Pacira Pharmaceuticals Incorporated | $34.51 | 2022-2024 | Exparel, Zilretta, Iovera |
| Nevro Corp. | $32.65 | 2019 | |
| Bioventus LLC | $30.09 | 2025 | Xcell |
| Foundation Fusion Solutions, LLC | $29.87 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.13 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vije listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.